Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Regulatory Toxicology and Pharmacology : RTP
|
January 20, 2016
It's difficult, but important, to make negative predictions
Richard V Williams, Alexander Amberg, Alessandro Brigo, et al.
Frontiers in Toxicology
|
November 29, 2023
<i>In silico</i> approaches in carcinogenicity hazard assessment: case study of pregabalin, a nongenotoxic mouse carcinogen
Douglas A Keller, Arianna Bassan, Alexander Amberg, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 7, 2015
Establishing best practise in the application of expert review of mutagenicity under ICH M7
Chris Barber, Alexander Amberg, Laura Custer, et al.
Toxicology and Applied Pharmacology
|
November 18, 2010
Cross-study and cross-omics comparisons of three nephrotoxic compounds reveal mechanistic insights and new candidate biomarkers
Katja A Matheis, Emmanuelle Com, Jean-Charles Gautier, et al.
Regulatory Toxicology and Pharmacology : RTP
|
December 29, 2015
Evaluation of a statistics-based Ames mutagenicity QSAR model and interpretation of the results obtained
Chris Barber, Alex Cayley, Thierry Hanser, et al.
Journal of Biochemical and Molecular Toxicology
|
May 9, 2019
Mechanistic investigations of the liver toxicity of the free fatty acid receptor 1 agonist fasiglifam (TAK875) and its primary metabolites
Timothy Ackerson, Alexander Amberg, Jens Atzrodt, et al.
ALTEX
|
December 3, 2023
Toward implementing virtual control groups in nonclinical safety studies
Emily Golden, David Allen, Alexander Amberg, et al.
Regulatory Toxicology and Pharmacology : RTP
|
May 15, 2013
Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities
Andreas Sutter, Alexander Amberg, Scott Boyer, et al.
Toxicology and Applied Pharmacology
|
October 5, 2010
The enhanced value of combining conventional and "omics" analyses in early assessment of drug-induced hepatobiliary injury
Heidrun Ellinger-Ziegelbauer, Melanie Adler, Alexander Amberg, et al.
Mutagenesis
|
September 7, 2018
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?
Alexander Amberg, Lennart T Anger, Joel Bercu, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Regulatory Toxicology and Pharmacology : RTP
|
January 20, 2016
It's difficult, but important, to make negative predictions
Richard V Williams, Alexander Amberg, Alessandro Brigo, et al.
Frontiers in Toxicology
|
November 29, 2023
<i>In silico</i> approaches in carcinogenicity hazard assessment: case study of pregabalin, a nongenotoxic mouse carcinogen
Douglas A Keller, Arianna Bassan, Alexander Amberg, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 7, 2015
Establishing best practise in the application of expert review of mutagenicity under ICH M7
Chris Barber, Alexander Amberg, Laura Custer, et al.
Toxicology and Applied Pharmacology
|
November 18, 2010
Cross-study and cross-omics comparisons of three nephrotoxic compounds reveal mechanistic insights and new candidate biomarkers
Katja A Matheis, Emmanuelle Com, Jean-Charles Gautier, et al.
Regulatory Toxicology and Pharmacology : RTP
|
December 29, 2015
Evaluation of a statistics-based Ames mutagenicity QSAR model and interpretation of the results obtained
Chris Barber, Alex Cayley, Thierry Hanser, et al.
Journal of Biochemical and Molecular Toxicology
|
May 9, 2019
Mechanistic investigations of the liver toxicity of the free fatty acid receptor 1 agonist fasiglifam (TAK875) and its primary metabolites
Timothy Ackerson, Alexander Amberg, Jens Atzrodt, et al.
ALTEX
|
December 3, 2023
Toward implementing virtual control groups in nonclinical safety studies
Emily Golden, David Allen, Alexander Amberg, et al.
Regulatory Toxicology and Pharmacology : RTP
|
May 15, 2013
Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities
Andreas Sutter, Alexander Amberg, Scott Boyer, et al.
Toxicology and Applied Pharmacology
|
October 5, 2010
The enhanced value of combining conventional and "omics" analyses in early assessment of drug-induced hepatobiliary injury
Heidrun Ellinger-Ziegelbauer, Melanie Adler, Alexander Amberg, et al.
Mutagenesis
|
September 7, 2018
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?
Alexander Amberg, Lennart T Anger, Joel Bercu, et al.
Page
of 5